2021 American Transplant Congress
Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients
*Purpose: Development of de novo donor-specific anti-HLA antibodies (dnDSA) after kidney transplantation remains strongly associated with antibody-mediated rejection (AMR), which leads to poor graft outcome.…2021 American Transplant Congress
Development and Validation of a Nomogram for Remnant Kidney Function After Living-donor Donation
The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
*Purpose: This study was to develop and validate a nomogram to predict remnant kidney function after living-donor kidney donation.*Methods: We conducted a retrospective cohort study…2021 American Transplant Congress
Dual Liver and Kidney Donors, What Makes Them Decide to Do It?
Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: There is incongruity between the transplant waiting list and the number of deceased donors available, therefore there is an enduring challenge to increase the…2021 American Transplant Congress
Trends in Liver Donors for Liver Transplantation Over Twenty Years: Donor Changes in Gender, Relationships, and Education, but Racial Disparities Remain
Gastroenterology and Hepatology, New York Presbyterian/Weill Cornell, New York, NY
*Purpose: Living donor liver transplant (LDLT) has grown over the past several decades as a response to critical organ shortages. Racial and ethnic disparities exist…2021 American Transplant Congress
Implications of Trends in Child to Parent Kidney Donation in Whites and African Americans
Nephrology, University of Chicago, Chicago, IL
*Purpose: Racial disparities in access to transplantation referral, wait listing and transplant receipt are well described. African Americans (AA) receive fewer living donor transplants than…2021 American Transplant Congress
Modifiable Barriers in Decision Making Around Living Donor Kidney Transplantation – A Rapid Scoping Review to Guide (DEAL-KD) Study
*Purpose: Living donor kidney transplantation (LDKT) is the optimal modality of renal replacement therapy for patients with advanced renal disease; associated with superior recipient and…2021 American Transplant Congress
Body Surface Adjusted vs Raw GFR in Predicting Long Term Outcomes of Kidney Donors. Who is Disadvantaged?
*Purpose: KDIGO and others recommend that GFR level acceptance (typically >80 ml/min) should be adjusted for body surface area (BSA) as GFR correlates highly with…2021 American Transplant Congress
Trends in Living Donor Transplantation in USA
Tampa General Hospital, Tampa, FL
*Purpose: Globally, living donation has improved access to organ transplantation and saved the lives of individuals with end-stage kidney disease and end-stage liver disease. In…2021 American Transplant Congress
Re-Do Hepatic Artery Reconstruction for Thrombosis Can Save Grafts and Patients without Retransplantation: Lessons Learned from 1,355Adult Living Donor Liver Transplantations
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Hepatic artery thrombosis (HAT) after liver transplantation is associated with a marked increase in morbidity, being the main cause of graft loss and bile…2021 American Transplant Congress
Associations of Lack of Insurance and Other Sociodemographic Traits with Deficiencies in Follow-Up After Living Kidney Donation
*Purpose: Follow-up after living kidney donation in the United States has improved with recent policy mandates. We hypothesized that lack of insurance at donation may…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 27
- Next Page »